SPRAVATO® Treatment for Depression
Spravato is an FDA-approved treatment for adults with treatment-resistant depression. Delivered under medical supervision, it offers an alternative option when traditional antidepressants have not been effective.
SPRAVATO® Treatment for Depression
Spravato is an FDA-approved treatment for adults with treatment-resistant depression. Delivered under medical supervision, it offers an alternative option when traditional antidepressants have not been effective.
What Is SPRAVATO®?
Spravato (esketamine) is a prescription nasal spray used to treat adults with treatment-resistant depression. Unlike traditional antidepressants, which are taken daily at home, Spravato is administered in a clinical setting under the supervision of a healthcare provider.
It works differently than standard medications by targeting specific receptors in the brain associated with mood regulation, offering a new pathway for patients who have not found relief with other treatments.
Treatment is administered in a controlled clinical setting under the supervision of trained medical professionals to ensure safety and effectiveness.
Who Is a Candidate for SPRAVATO®?
Spravato may be considered for individuals experiencing treatment-resistant depression or ongoing symptoms that have not improved with traditional antidepressant medications. A full psychiatric evaluation is required to determine if this treatment is appropriate for your needs.
You may be a candidate if you:
- Have tried multiple antidepressants without success
- Continue to experience moderate to severe depression
- Have symptoms interfering with daily life
- Are seeking an alternative to traditional medication approaches
How Spravato Treatment Works
Spravato is administered as a nasal spray in a controlled clinical setting. Each session is supervised by trained medical staff to ensure safety and effectiveness.
Patients are monitored during and after treatment, as the medication can cause temporary side effects such as dizziness or changes in perception. Because of this, patients are required to remain in the clinic for observation following each session.
Treatment is typically delivered in phases, starting with more frequent visits and gradually spacing out based on your response and provider recommendations.
How Spravato Differs from Traditional Antidepressants
Traditional antidepressants often take several weeks to show results and may not be effective for all patients. Spravato offers a different mechanism of action, working more rapidly in some individuals and targeting pathways not addressed by standard medications.
It is used alongside an oral antidepressant and is part of a comprehensive psychiatric care plan developed by your provider.
Safety and Clinical Oversight
Spravato is only available through a restricted program and must be administered in a certified healthcare setting. This ensures that each patient receives appropriate monitoring and support during treatment.
Our team follows established safety protocols, including observation after each session and coordination with your broader behavioral health care plan.
Spravato as Part of Psychiatric Care
Spravato is not a standalone treatment. It is part of a broader psychiatric care approach that may include medication management, therapy, and ongoing evaluation.
Your provider will determine how Spravato fits into your overall treatment plan and ensure that it aligns with your specific mental health needs.
Where to Access Spravato Treatment
Spravato treatment is available at select locations and must be administered in person under medical supervision.
Schedule a Spravato Evaluation
If you are struggling with depression that has not improved with traditional treatments, Spravato may be an option. Schedule an evaluation to determine if this treatment is right for you.
Frequently Asked Questions
Spravato contains esketamine, a form of ketamine, but it is specifically approved and regulated for the treatment of depression in a clinical setting.
Appointments typically last a few hours, including administration and post-treatment monitoring.
Yes, patients are required to arrange transportation after each session due to potential side effects.
Some patients may begin to notice improvement sooner than with traditional antidepressants, though results vary by individual.
If you can’t find answers to your questions in our FAQ, you can always contact us below or call us at 866-888-4947.
We’ll get back to you ASAP.